Your search for major depressive disorder returned 118 results

For adults with bipolar depression, tDCS seems to be safe and effective as an add-on intervention.

The FDA has cleared Nexstim’s NBT system for the treatment of major depressive disorder.

Most patients undergoing skull base irradiation for cancer do not have detectable cognitive impairment.

Escitalopram may be better for the treatment of depression than tDCS.

Prescriptions for benzodiazepine lasting 2-3 months or more and marked dose increases should be avoided.

Effectively treating pain may help improve cognitive and functional outcomes in patients with depression.

Migraine was more significantly associated with pain or muscle soreness than anxiety disorders in patients with depression.

Overall, 26 of the 34 studies suggested a positive relationship between insomnia and depression.

Time spent on mobile phones and social media may contribute to the rise in depression.

Patients with type 2 diabetes and major depressive disorder spent a significant amount of time experiencing depressive episodes.

Those suffering from depression and those diagnosed with temporal lobe epilepsy present with dysfunction across several cognitive domains.

HIV-infected adults with major depressive disorder have a 30% increased risk for acute myocardial infarction.

Results indicate that patients with AUD show significant impairments in social problem resolution task.

New findings suggest shared genetic etiology vs causal relationship in comorbid migraine and depression.

The odd relationship may have more to do with the mental disorder than the drugs.

Sixty percent of patients responded to treatment.

The drug was found to work quickly in patients with clinical major depression.

The device is used to condition the patient to reduce or stop their aggressive behavior.

Depression of some degree is prevalent in a majority of patients with ALS.

Screening recommended for those aged 12 to 18, however there is insufficient evidence to assess for children aged 11 and younger.

While the optimal depression screening timing and interval remains unknown, the USPSTF suggests screening all adults, regardless of risk factors, who have not been screened previously.

A family history of mental illness increases the risk of such disorders in children taking stimulants.

Changes were more pronounced in depressed volunteers.

Hippocampal DVR was strongly correlated with the Beck’s Depression Inventory score in patients with MS.

Depression, substance abuse, and suicidal ideation are commonly reported in patients who have chronic pain.

A combination of nonpharmacologic and pharmacologic therapies will help manage this far-reaching disorder.

There was insufficient evidence to recommend screening in children aged 11 and younger.

Patients who experienced only one episode of major depression did not show any signs of hippocampal volume reduction